Inventor · disambiguated record
Hiroshi Terashima
Also filed as: TERASHIMA HIROSHI
11 granted patents·193 citations·filing 1976–1991
90Inventor score
Files withONO PHARMACEUTICAL CO11
Top patents by PatentIndex Score
11 records- 0190US4464382ARhodanine derivatives, process for their preparation, and aldose reductase inhibitor containing the rhodanine derivatives as active ingredientONO PHARMACEUTICAL CO·Filed 1981·Granted Aug 7, 1984·42 cites·5 claims
- 0285US4831045ARhodanine derivatives, process for their preparation, and aldose reductase inhibitor containing the rhodanine derivatives as active ingredientONO PHARMACEUTICAL CO·Filed 1987·Granted May 16, 1989·45 cites·17 claims
- 0384US4791126ARhodanine derivatives, process for their preparation, and aldose reductase inhibitor containing the rhodanine derivatives as active ingredientsONO PHARMACEUTICAL CO·Filed 1987·Granted Dec 13, 1988·25 cites·15 claims
- 0482US4935240ABenzoylaminophenoxybutanoic acid derivativesONO PHARMACEUTICAL CO·Filed 1988·Granted Jun 19, 1990·32 cites·19 claims
- 0581US4980372ABenzoylaminophenoxybutanoic acid derivativesONO PHARMACEUTICAL CO·Filed 1988·Granted Dec 25, 1990·30 cites·11 claims
- 0659US4863963ANovel cinnamoylamide derivativesONO PHARMACEUTICAL CO·Filed 1988·Granted Sep 5, 1989·8 cites·7 claims
- 0749US4446143ARhodanine derivativesONO PHARMACEUTICAL CO·Filed 1981·Granted May 1, 1984·3 cites·41 claims
- 0842US4030977AMethod for purification of physiologically active substance using enzyme-enzyme inhibitor systemONO PHARMACEUTICAL CO·Filed 1976·Granted Jun 21, 1977·6 cites·4 claims
- 0929US5191113ACinnamoylamide derivativesONO PHARMACEUTICAL CO·Filed 1991·Granted Mar 2, 1993·1 cites·3 claims
- 1029US5093366ANovel cinnamoylamide derivativesONO PHARMACEUTICAL CO·Filed 1991·Granted Mar 3, 1992·1 cites·4 claims
- 1129US5037852ACinnamoylamide derivativesONO PHARMACEUTICAL CO·Filed 1990·Granted Aug 6, 1991·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when Hiroshi Terashima files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →